Dr. Marz addresses the problem of what sweetening agents should ideally be used by diabetics, and others with conditions such as hypoglycemia and candida overgrowth that require minimal blood glucose elevation. Research is presented on Stevia rabaudina, which has been shown not to increase blood glucose levels. Thirteen million people in the United States have diabetes, and there are an estimated six and a half million additional undiagnosed cases. The incidence of diabetes is expected to double in fifteen years. Additionally, twenty-eight million people show impaired glucose tolerance. Omnibalance, a new sweetener formulation which contains Stevia, can play a significant role.